These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 32641160)

  • 1. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study.
    Lv PP; Jin M; Rao JP; Chen J; Wang LQ; Huang CC; Yang SQ; Yao QP; Feng L; Shen JM; Feng C
    BMC Endocr Disord; 2020 Jul; 20(1):101. PubMed ID: 32641160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO
    Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
    Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes.
    Liu XH; Wu XH; Yang S
    Arch Gynecol Obstet; 2019 Dec; 300(6):1773-1783. PubMed ID: 31631249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
    Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
    Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
    Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
    Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The level distribution of serum AMH in different clinical manifestations of women of childbearing age].
    Zhang QL; Yue CY; Zhang B; Wang ZH; Ying CM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):985-989. PubMed ID: 35899353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.